发明名称 Indanylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
摘要 The present invention relates to compounds of general formula I,; wherein the groups R, R1, R2, R3, m and n are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2. Furthermore, the invention relates to novel intermediates, useful for the synthesis of compounds of formula I.
申请公布号 US9617251(B2) 申请公布日期 2017.04.11
申请号 US201615225038 申请日期 2016.08.01
申请人 Boehringer Ingelheim International GmbH 发明人 Eckhardt Matthias;Peters Stefan;Wagner Holger
分类号 C07D413/12;C07D401/12;A61K31/4439;A61K45/06;C07D213/74;A61K31/4418;C07D405/12;A61K31/443;A61K31/4433;A61K31/4427;A61K31/444;A61K31/497;A61K31/513;C07D409/12;A61K31/4436 主分类号 C07D413/12
代理机构 代理人 Morris Michael P.;Kershner David L.
主权项 1. A compound of formula (I) wherein R is selected from a group consisting of H, F, Cl, Br, I, C1-6-alkyl, C2-6-alkenyl, C2-6-alkynyl, C3-6-cycloalkyl, NC—, HNRN—C(═O)—, C1-4-alkyl-NRN—C(═O)—, C3-6-cycloalkyl-NRN—C(═O)—, heterocyclyl-NRN—C(═O)—, heteroaryl-NRN—C(═O)—, HOOC—, C1-4-alkyl-O—C(═O)—, O2N—, HRNN—, C1-4-alkyl-RNN—, C1-4-alkyl-C(═O)NRN—, C1-4-cycloalkyl-C(═O)NRN—, heterocyclyl-C(═O)NRN—, heteroaryl-C(═O)NRN—, C1-4-alkyl-S(═O)2NRN—, C3-6-cycloalkyl-S(═O)2NRN—, heterocyclyl-S(═O)2NRN—, heteroaryl-S(═O)2NRN—, HO—, C1-6-alkyl-O—, HOOC—C1-3-alkyl-O—, heterocyclyl-C1-3-alkyl-O—, phenyl-C1-3-alkyl-O—, C3-6-cyclo-alkyl-O—, heterocyclyl-O—, heteroaryl-O—, C1-4-alkyl-S—, C3-6-cycloalkyl-S—, hetero-cyclyl-S—, C1-4-alkyl-S(═O)—, C3-6-cycloalkyl-S(═O)—, heterocyclyl-S(═O)—, C1-4-alkyl-S(═O)2—, C3-6-cycloalkyl-S(═O)2—, heterocyclyl-S(═O)2—, phenyl-S(═O)2—, heteroaryl-S(═O)2—, HNRN—S(═O)2—, C1-4-alkyl-NRN—S(═O)2—, heterocyclyl, phenyl, and heteroaryl,wherein each alkyl, cycloalkyl, and heterocyclyl group or sub-group within the groups forming R is optionally substituted with 1 or more F atoms and optionally substituted with 1 to 3 groups independently selected from Cl, C1-3-alkyl, NC—, (RN)2N—, HO—, C1-3-alkyl-O—, and C1-3-alkyl-S(═O)2—; andwherein each phenyl and heteroaryl group or sub-group within the groups forming R is optionally substituted with 1 to 5 substituents independently selected from F, Cl, C1-3-alkyl, HF2C—, F3C—, NC—, (RN)2N—, HO—, C1-3-alkyl-O—, F3C—O—, and C1-3-alkyl-S(═O)2—;wherein each heterocyclyl group or sub-group within the groups forming R is selected from a cyclobutyl group wherein 1 CH2 group is replaced by —NRN— or —O—;a C5-6-cycloalkyl group wherein 1 CH2 group is replaced by —O(═O)—, —NRN—, —O— or —S(═O)2— and/or 1 CH group is replaced by N;a C5-6-cycloalkyl group wherein 1 CH2 group is replaced by —NRN— or —O—, a second CH2 group is replaced by —NRN—, —O(═O)— or —S(═O)2— and/or 1 CH group is replaced by N; anda C5-6-cycloalkyl group wherein 2 CH2 groups are replaced by —NRN— or 1 CH2 group by —NRN— and the other by —O— and a third CH2 group is replaced by —O(═O)— or —S(═O)2— and/or 1 CH group is replaced by N;wherein each heteroaryl group or sub-group within the groups forming R is selected from tetrazolyl and a 5- or 6-membered heteroaromatic ring which contains 1, 2, or 3 heteroatoms independently of each other selected from ═N—, —NRN—, —O—, and —S—, wherein in heteroaromatic groups containing a —HC═N— unit this group is optionally replaced by —NRN—C(═O)—;wherein in heteroaryl and heterocyclyl rings with one or more NH groups, each of said NH groups is replaced by NRN; R1 is selected from a group consisting of H, F, Cl, C1-4-alkyl, C3-6-cycloalkyl-, HO—C1-4-alkyl, C1-4-alkyl-O—C1-4-alkyl, NC—, HO—, C1-4-alkyl-O—, C3-6-cycloalkyl-O—, C1-4-alkyl-S—, C1-4-alkyl-S(O)—, and C1-4-alkyl-S(O)2—, wherein any alkyl and cycloalkyl group or sub-group within the groups forming R1 is optionally substituted with 1 or more F atoms, and wherein multiple R1 may be identical or different if m is 2, 3 or 4; m is an integer selected from 1, 2, 3, and 4; R2 is H, F, Cl, C1-4-alkyl, NC—, or C1-4-alkyloxy, wherein any alkyl group or sub-group within the groups forming R2 is optionally substituted with 1 or more F atoms, and wherein multiple R2 may be identical or different if n is 2 or 3; n is an integer selected from 1, 2, and 3; R3 is H, F, Cl, C1-4-alkyl, NC—, or C1-4-alkyl-O—, wherein each alkyl group or sub-group within the groups forming R3 is optionally substituted with 1 or more F atoms; RN is independently of each other selected from a group consisting of H, C1-4-alkyl, HO—(C1-4-alkyl)-H2C—, C1-3-alkyl-O—C1-4-alkyl-, C1-4-alkyl-C(═O)—, C1-4-alkyl-NH—C(═O)—, C1-4-alkyl-N(C1-4-alkyl)-C(═O)—, C1-4-alkyl-O—C(═O)—, and C1-4-alkyl-S(═O)2—, wherein each alkyl group or sub-group within the groups forming RN is optionally substituted with 1 or more F atoms; wherein in any definition mentioned hereinbefore, if not specified otherwise, any alkyl group or sub-group may be straight-chained or branched, or a salt thereof.
地址 Ingelheim am Rhein DE